Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2008
01/31/2008US20080028485 Inbred corn line UNW1
01/31/2008US20080028484 Inbred corn line MM6
01/31/2008US20080028483 Inbred corn line MN5
01/31/2008US20080028482 Corn Plant Mon88017 and Compositions and Methods for Detection Thereof
01/31/2008US20080028481 Chimeric gene containing several herbicide tolerance genes, plant cell and plant resistant to several herbicides
01/31/2008US20080028480 Markers for Salinity Tolerance in Wheat Plants and the Use Thereof in Breeding Programs
01/31/2008US20080028479 Method for making genetic modifications
01/31/2008US20080027216 siRNA targeting sodium channel, voltage-gated, type X, alpha (SCN10A)
01/31/2008US20080027215 siRNA targeting vascular endothelial growth factor (VEGF)
01/31/2008US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes
01/31/2008US20080027213 Chimeric immunogens
01/31/2008US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders
01/31/2008US20080027145 Therapeutic Molecules and Methods for Generating and/or Selecting Same
01/31/2008US20080027106 Methods of treating psychosis and schizphrenia based on polymorphisms in the cntf gene
01/31/2008US20080027021 Use of cpg oligodeoxynucleotides to induce angiogenesis
01/31/2008US20080027020 Human Neuropeptide Receptor
01/31/2008US20080027015 Methods and Materials for Modulating Enac-Beta
01/31/2008US20080027004 Phosphorylated COP1 molecules and uses thereof
01/31/2008US20080027002 Compositions and methods for targeting cancer-specific transcription complexes
01/31/2008US20080026999 Dehydration, cyclization of peptide; prevention, therapy for bacteria infections; amino acid sequences
01/31/2008US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family
01/31/2008US20080026989 Human Ependymin
01/31/2008US20080026985 Control of gene expression
01/31/2008US20080026982 Mutant APOBEC3G molecules for inhibiting replication of HIV
01/31/2008US20080026976 Highly productive alpha-amylases
01/31/2008US20080026952 HCV replicon shuttle vectors
01/31/2008US20080026951 Methods and Compositions Involving microRNA
01/31/2008US20080026948 Protein (poly)peptides libraries
01/31/2008US20080026467 Novel Agents for the Prevention of Leishmaniosis
01/31/2008US20080026466 Comprises expression vector coding regulatory sequences for efficient expression of heterologous polypeptides which confer herbicide, disease and insect resistance in plants; improved stability or shelf life
01/31/2008US20080026459 Differential expression via marker within genome; fluorescence activated cell sorting
01/31/2008US20080026458 CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS
01/31/2008US20080026457 Ungulates with genetically modified immune systems
01/31/2008US20080026440 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
01/31/2008US20080026439 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026438 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026437 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026436 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026435 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026434 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026432 Novel L-Threonine Importer From Corynebacterium And A Preparation Method Of A Strain Producing L-Threonine
01/31/2008US20080026428 Method for producing nucleotide by fermentation
01/31/2008US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF
01/31/2008US20080026426 Anti-infective therapy
01/31/2008US20080026424 having replacements in the amino acid sequence and where the subdomain of the polypeptide is modified so that the rate stability is maintained relative to the wild-type polypeptide
01/31/2008US20080026422 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide
01/31/2008US20080026421 Transgenic cells comprising peroxisomal membrane polypeptide (PMP) for transport of intracellular proteins to ouside of cell
01/31/2008US20080026404 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
01/31/2008US20080026402 Hematopoietin receptors HPR1 and HPR2
01/31/2008US20080026399 treating bladder and lower urinary tract syndromes particularly irrative symptoms using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists; drug screening
01/31/2008US20080026398 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
01/31/2008US20080026396 Method and nucleic acids for the analysis of astrocytomas
01/31/2008US20080026395 Method of detection of prostate cancer
01/31/2008US20080026376 KEX2 cleavage regions of recombinant fusion proteins
01/31/2008US20080026372 In vitro processes for producing multiple copies of primer sequence-free specific nucleic acid
01/31/2008US20080026363 Acetyl coa carboxylase 2 sequences and methods
01/31/2008US20080026072 glycoproteins having alpha 1,4-linked N-acetylglucosamine residue from milk of mammal containing carrier polypeptide with alpha 1,4-N-acetylglucosaminyl transferase; for treatment or prevention of gastric ulcers
01/31/2008US20080026071 Microparticles for delivery of heterologous nucleic acids
01/31/2008US20080026048 Reovirus for the treatment of cellular proliferative disorders
01/31/2008US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
01/31/2008US20080026011 Immunostimulatory nucleic acid molecules
01/31/2008US20080026005 Multicopy-integration of heterologous genes and expression in methylobacterium
01/31/2008US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor
01/31/2008US20080025990 anti-IGFR1 antibodies; combination with topoisomerase inhibitor such as irinotecanp; antitumor
01/31/2008US20080025988 Monoclonal Antibody And Use Thereof
01/31/2008US20080025979 Programmed Death 1(PD-1); bispecific antibodies comprising antibodies against human T cell receptor complex or human B cell receptor complex; autoimmune diseases
01/31/2008US20080025968 Methods and Agents for Immune Modulation and Methods for Identifying Immune Modulators
01/31/2008US20080025958 Bar coded library; detecting gene sensitive to tumors; transfection of stem cells; anticancer agents
01/31/2008US20080025957 Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them
01/31/2008US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain
01/31/2008US20080022931 Methods for Injecting Avian Eggs
01/31/2008CA2659353A1 Composition and method for treatment of tumors
01/31/2008CA2659297A1 Plants defective for soluble starch synthase iv (ssiv) activity, methods for obtaining the same, and uses thereof
01/31/2008CA2659262A1 Improved vaccines and methods for using the same
01/31/2008CA2658805A1 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
01/31/2008CA2658713A1 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
01/31/2008CA2658654A1 Exendin fusion proteins
01/31/2008CA2658595A1 Regulatory nucleic acid elements
01/31/2008CA2658563A1 Crohn disease susceptibility gene
01/31/2008CA2658204A1 Human artificial chromosome (hac) vector and human cell medicine comprising same
01/31/2008CA2657135A1 High-cell density fed-batch fermentation process for producing recombinant protein
01/31/2008CA2647984A1 Direct regeneration of plantlets in jatropha curcas
01/30/2008EP1882941A2 Magnetic bead extraction device for separating and purifying target biomolecules and microfluidic system including the same
01/30/2008EP1882743A1 Method for producing protein
01/30/2008EP1882742A1 Plants defective for soluble starch synthase IV (SSIV) activity, methods for obtaining the same, and uses thereof
01/30/2008EP1882741A1 Recombinant Mycobacterium strain expressing a mycobacterial FAP protein under the control of a promoter active under hypoxia and its application for cancer therapy
01/30/2008EP1882740A1 N-acetyl-(R,S)-B-amino acid acylase gene
01/30/2008EP1882739A1 Nucleic acid extraction method
01/30/2008EP1882738A1 Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods
01/30/2008EP1882737A1 Process for production of l-serine derivative and enzyme used in the process
01/30/2008EP1882696A2 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
01/30/2008EP1882392A2 Genes and uses for plant improvement
01/30/2008EP1882047A2 Compositions, methods and kits for real-time nucleic acid analysis in live cells
01/30/2008EP1882038A2 Corn plants and seed enhanced for asparagine and protein
01/30/2008EP1882037A2 Expression cassettes for seed-preferential expression in plants
01/30/2008EP1882036A1 Sequential cloning system
01/30/2008EP1882035A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
01/30/2008EP1882034A2 New antibiotic-sensitive lactic acid bacteria strains
01/30/2008EP1882033A2 Materials and methods for regulating blood flow
01/30/2008EP1881992A2 Isolated aqdecay photoprotein and use thereof